| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |